Ishii Y, Fujimoto J, Kon S, Ogasawara M, Koshiba H, Mikuni C, Kikuchi K
Am J Hematol. 1982 May;12(3):251-60. doi: 10.1002/ajh.2830120307.
Leukemic cells from eight adult patients with various types of T-cell leukemias, including one patient with lymphosarcoma cell leukemia (T-LSL), two patients with chronic lymphocytic leukemia (T-CLL), and five patients with adult T-cell leukemia (ATL), were analyzed for their surface antigenic phenotypes with a series of monoclonal antibodies directing to human T-cell differentiation antigens. All of the leukemic T cells studied were regarded as being of post-thymic T-cell origin because of their ability to form rosettes with sheep red cells under the condition at 4 degrees C but not 37 degrees C as well as the expression of human Ly-1-like but not TL-like antigen on their cell surfaces. By using monoclonal antibodies to a variety of human of three distinct categories. Thus, one patient with T-LSL had cells with Leu-1+2a+3a+ phenotype, which might reflect possible post-thymic precursor T cells, whereas one patient with T-CLL had cells with the same phenotype (Leu-1+2a+3a-) as normal cytotoxic/suppressor T cells. The latter cells also expressed Ia antigens as defined by monoclonal antihuman Ia antibody. The remaining six cases, including one T-CLL and five ATL patients had leukemic cells with the same phenotype (Leu-1+2a-3a+) as normally found on helper/inducer T cells, despite distinct clinical and immunological features between T-CLL and ATL. Some clinical findings observed in those patients may reflect functional activities retained by their leukemic T cells.
运用一系列针对人类T细胞分化抗原的单克隆抗体,对8例患有不同类型T细胞白血病的成年患者的白血病细胞进行了表面抗原表型分析,这些患者包括1例淋巴肉瘤细胞白血病(T-LSL)患者、2例慢性淋巴细胞白血病(T-CLL)患者和5例成人T细胞白血病(ATL)患者。所有研究的白血病T细胞都被认为起源于胸腺后的T细胞,这是因为它们在4℃而非37℃的条件下能够与绵羊红细胞形成玫瑰花结,并且其细胞表面表达人类Ly-1样抗原而非TL样抗原。通过使用针对多种人类T细胞分化抗原的单克隆抗体,发现这些白血病T细胞可分为三个不同类别。因此,1例T-LSL患者的细胞具有Leu-1+2a+3a+表型,这可能反映了胸腺后前体T细胞的情况,而1例T-CLL患者的细胞具有与正常细胞毒性/抑制性T细胞相同的表型(Leu-1+2a+3a-)。后一种细胞还表达了由单克隆抗人Ia抗体定义的Ia抗原。其余6例,包括1例T-CLL患者和5例ATL患者,其白血病细胞具有与正常辅助/诱导性T细胞相同的表型(Leu-1+2a-3a+),尽管T-CLL和ATL之间存在明显的临床和免疫学特征差异。在这些患者中观察到的一些临床发现可能反映了其白血病T细胞保留的功能活性。